Drug Discovery Featured Articles & Applications

1. Early Decisions That Shape Success In CNS Drug Development And Commercialization, Part 2 8/11/2026

   In part 2, Ginger continues to provide insights for R&D teams on CNS development and commercialization.

2. July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing 8/7/2026

   Mathini Ilancheran updates us on how delayed U.S. tariffs on generic drug imports could reshape supply, sourcing, and trial planning.

3. Why Ending Rh Disease Requires More Than A Breakthrough (Part 3 of 3) 8/5/2026

   Rh disease has been preventable for decades. Yet babies still die worldwide because access, supply, and infrastructure have not caught up.

4. Early Decisions That Shape Success In CNS Drug Development And Commercialization, Part 1 8/4/2026

   In part 1, we caught up with Ginger Johnson, SVP and neuroscience lead at Lumanity, to discuss how companies can connect the science to the realities of CNS drug development earlier

5. The Changing Role Of Computational Mechanics In Drug Discovery 8/3/2026

   Computational models will never replace experimental biology, but their emerging role is different.

6. Beyond Binder Design: Why AI's Next Frontier Is Designing Multispecific Antibodies 7/31/2026

   Many of the therapies with the greatest potential to improve patient outcomes are complex multispecifics, where the data simply doesn't exist.

7. Drug Discovery AI Has A Ground Truth Problem 7/27/2026

   If the goal is more healthy years of life, the bottlenecks are target identification, target validation, and clinical testing. Why is AI not transforming those steps? Because the data are not there.

8. Fragment-Based Drug Discovery 2.0, Part 2: Practical Workflow, Difficult Target Classes, And Emerging Capabilities 7/27/2026

   Part 2 focuses on the practical workflow, difficult target classes, emerging capabilities, and the criteria for translating these technologies into better discovery decisions.

9. Chinese Competition And The Future Of Science: Insights From The U.S. Science Summit 7/24/2026

   At BiotechTV’s U.S. Science Summit, biotech leaders discussed China, AI, scientific storytelling, and what it will take to protect U.S. innovation.

10. Fragment-Based Drug Discovery 2.0, Part 1: Faster, Cleaner Weak-Binding Hit Discovery 7/24/2026

    This article examines the advances in ¹⁹F NMR, ultra-high-field instrumentation, and contrast-engineered screening.